Vivantes hospital in Berlin chooses SensoDetect Technology

juni 29, 2017

No Comments

Vivantes hospital in Berlin will use Sensodetect Technology to measure impact of dialyses on patiens with kidney disease.
 
One of the main challenges for patients with kidney disease is the impact dialysis has on the brain (structural brain abnormalities and cognitive impairment). This can lead to the patient not attending treatments or mismanaging their medications, which has a profound impact on the patient and can ultimately lead to mortality.
To this date it is not clear what in dialysis causes this changes in the patient’s brain.
 
For further reading, go to AktieTorget.

Share this article

Malinee Granhof

Kommentera

E-postadressen publiceras inte. Obligatoriska fält är märkta *

*

×

Make an appointment and we’ll contact you.

Translate »